Company news
Biodesix, Inc. (NASDAQ:BDSX) news
Every Biodesix, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
August 4, 2026
Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Te...
May 11, 2026
Biodesix Announces First Quarter 2026 Results and Highlights
May 4, 2026
Biodesix Recognized as a Top Workplace for Third Consecutive Year
April 9, 2026
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
April 6, 2026
Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis
March 20, 2026
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
February 26, 2026
Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 12, 2026
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)
January 12, 2026
Biodesix to Present New Data at Two Major Upcoming Scientific Meetings
December 3, 2025
Biodesix Announces Third Quarter 2025 Results and Highlights
November 3, 2025
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting
October 30, 2025
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays
October 22, 2025
Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting
October 15, 2025
Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American L...
October 6, 2025
Biodesix Announces One-for-Twenty Reverse Stock Split
September 11, 2025
Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference
September 5, 2025
Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics
August 19, 2025
Biodesix Announces Second Quarter 2025 Results and Highlights
August 7, 2025
Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference
August 5, 2025
Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025
July 24, 2025
Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs ...
June 10, 2025
Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting
May 22, 2025
Biodesix to Participate in Upcoming Investor Conferences
May 21, 2025
Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS
May 15, 2025
Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award
May 14, 2025
Biodesix Announces First Quarter 2025 Results and Highlights
May 13, 2025
Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025
April 29, 2025
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA ...
April 23, 2025
Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results
March 3, 2025
Biodesix to Present at TD Cowen 45th Annual Health Care Conference
February 26, 2025
Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
February 18, 2025
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)
January 10, 2025
Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study
January 7, 2025
Biodesix Announces Third Quarter 2024 Results and Highlights
November 1, 2024
Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study
October 7, 2024
Biodesix Announces Second Quarter 2024 Results and Highlights
August 7, 2024
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
May 8, 2024
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
April 24, 2024
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
April 5, 2024
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
March 25, 2024
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
March 1, 2024
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
February 16, 2024
Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method
November 14, 2023
Biodesix Announces Third Quarter 2023 Results and Highlights
November 7, 2023
Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023
October 24, 2023
Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer
September 7, 2023
Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer
August 22, 2023
Biodesix Announces Second Quarter 2023 Results and Highlights
August 7, 2023